CBRE: Meds and Eds Position Boston Ninth for 2023 CRE Investment
Boston has been ranked as the nation’s ninth top target for commercial real estate investment by CBRE’s 2023 U.S. Investor Intentions Survey.
“Despite rising cost for debt capital and fears of a potential recession, the Boston market remains one of the top markets for investors given the stability of the local economy with the meds and eds sectors leading the way,” said CBRE vice chairman Simon Butler.
“Buyers and lenders have been increasingly selective given the Fed’s monetary policy and shifts in underwriting criteria,” added CBRE EVP Heather Brown. “But a lack of quality product and rising rents in many sectors of the market, including office, industrial and retail, still make Boston one of the most active markets in the nation.”
The survey found that more investors are prioritizing high-performing secondary markets in 2023 (as opposed to gateway markets), particularly those with strong job and population growth prospects, which can translate into greater potential for both equity and income growth.
Top Ten CRE Investor Preferred Markets
- Dallas/Ft. Worth
- Miami/South Florida
- Los Angeles